DICP OpenIR
学科主题物理化学
Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms
Zhu, Liangliang1,2; Ge, Guangbo1; Zhang, Hongbo3; Liu, Huixin1; He, Guiyuan1,2; Liang, Sicheng1; Zhang, Yanyan1; Fang, Zhongze1; Dong, Peipei1; Finel, Moshe3; Yang, Ling1; Yang L(杨凌)
刊名DRUG METABOLISM AND DISPOSITION
2012-03-01
DOI10.1124/dmd.111.042192
40期:3页:529-538
收录类别SCI
文章类型Article
部门归属18
项目归属1806
产权排名1,1
WOS标题词Science & Technology ; Life Sciences & Biomedicine
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]HUMAN LIVER-MICROSOMES ; DRUG-GLUCURONIDATION ; SUBSTRATE ; EXPRESSION ; CYTOCHROME-P450 ; SPECIFICITY ; SELECTIVITY ; METABOLISM ; DOPAMINE ; KINETICS
英文摘要Magnolol is a food additive that is often found in mints and gums. Human exposure to this compound can reach a high dose; thus, characterization of magnolol disposition in humans is very important. Previous studies indicated that magnolol can undergo extensive glucuronidation in humans in vivo. In this study, in vitro assays were used to characterize the glucuronidation pathway in human liver and intestine. Assays with recombinant human UDP-glucuronosyltransferase enzymes (UGTs) revealed that multiple UGT isoforms were involved in magnolol glucuronidation, including UGT1A1, -1A3, -1A7, -1A8, -1A9, -1A10, and -2B7. Magnolol glucuronidation by human liver microsomes (HLM), human intestine microsomes (HIM), and most recombinant UGTs exhibited strong substrate inhibition kinetics. The degree of substrate inhibition was relatively low in the case of UGT1A10, whereas the reaction catalyzed by UGT1A9 followed biphasic kinetics. Chemical inhibition studies and the relative activity factor (RAF) approach were used to identify the individual UGTs that played important roles in magnolol glucuronidation in HLM and HIM. The results indicate that UGT2B7 is mainly responsible for the reaction in HLM, whereas UGT2B7 and UGT1A10 are significant contributors in HIM. In summary, the current study clarifies the glucuronidation pathway of magnolol and demonstrates that the RAF approach can be used as an efficient method for deciphering the roles of individual UGTs in a given glucuronidation pathway in the native tissue that is catalyzed by multiple isoforms with variable and atypical kinetics.
语种英语
WOS记录号WOS:000300610100017
引用统计
文献类型期刊论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/118375
专题中国科学院大连化学物理研究所
通讯作者Yang L(杨凌)
作者单位1.Chinese Acad Sci, Lab Pharmaceut Resource Discovery, Dalian Inst Chem Phys, Dalian 116023, Peoples R China
2.Chinese Acad Sci, Grad Univ, Beijing, Peoples R China
3.Univ Helsinki, Ctr Drug Res, Fac Pharm, Helsinki, Finland
推荐引用方式
GB/T 7714
Zhu, Liangliang,Ge, Guangbo,Zhang, Hongbo,et al. Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms[J]. DRUG METABOLISM AND DISPOSITION,2012,40(3):529-538.
APA Zhu, Liangliang.,Ge, Guangbo.,Zhang, Hongbo.,Liu, Huixin.,He, Guiyuan.,...&杨凌.(2012).Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms.DRUG METABOLISM AND DISPOSITION,40(3),529-538.
MLA Zhu, Liangliang,et al."Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms".DRUG METABOLISM AND DISPOSITION 40.3(2012):529-538.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
201267zKVmztTL.PDF(1243KB) 开放获取--请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhu, Liangliang]的文章
[Ge, Guangbo]的文章
[Zhang, Hongbo]的文章
百度学术
百度学术中相似的文章
[Zhu, Liangliang]的文章
[Ge, Guangbo]的文章
[Zhang, Hongbo]的文章
必应学术
必应学术中相似的文章
[Zhu, Liangliang]的文章
[Ge, Guangbo]的文章
[Zhang, Hongbo]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。